1,000+ Opportunities
Find the right grant
Search federal, foundation, and corporate grants with AI — or browse by agency, topic, and state.
FY27 Training Awards is sponsored by Breakthrough T1D (formerly JDRF). This program offers training awards for applicants proposing human subject research on long-term complications of Type 1 Diabetes, specifically diabetic eye, kidney, and cardiovascular disease. This includes interventional or observational trials, as well as analysis of clinical biosamples or data.
Get alerted about grants like this
Save a search for “Breakthrough T1D (formerly JDRF)” or related topics and get emailed when new opportunities appear.
Search similar grants →Extracted from the official opportunity page/RFP to help you evaluate fit faster.
A **. gov** website belongs to an official government organization in the United States.
* How to Apply for Grants * **Applicant Resources** * Adobe Software Compatibility * Submitting UTF-8 Special Characters * Encountering Error Messages * Grantor Standard Language * Submitting UTF-8 Special Characters * **Applicant System-To-System** * Reference Implementation * **Grantor System-To-System** * Reference Implementation * SF-424 Individual Family * SF-424 Mandatory Family * SF-424 Short Organization Family * Post-Award Reporting Forms * Country and State Lists Updates * **Manage Subscriptions** * Program Management Office * Grants.
gov Maintenance Calendar Mentored Clinical Scientist Research Career Development Award (Parent K08) Department of Health and Human Services National Institutes of Health Document Type:Grants Notice Funding Opportunity Number:PA-11-193 Funding Opportunity Title:Mentored Clinical Scientist Research Career Development Award (Parent K08) Opportunity Category:Discretionary Opportunity Category Explanation: Funding Instrument Type:Grant Category of Funding Activity:Education Employment, Labor and Training Income Security and Social Services Expected Number of Awards: Assistance Listings:93.
113 -- Environmental Health 93. 121 -- Oral Diseases and Disorders Research 93. 173 -- Research Related to Deafness and Communication Disorders 93.
213 -- Research and Training in Complementary and Alternative Medicine 93. 233 -- National Center on Sleep Disorders Research 93. 279 -- Drug Abuse and Addiction Research Programs 93.
281 -- Mental Health Research Career/Scientist Development Awards 93. 286 -- Discovery and Applied Research for Technological Innovations to Improve Human Health 93. 398 -- Cancer Research Manpower 93.
837 -- Cardiovascular Diseases Research 93. 838 -- Lung Diseases Research 93. 839 -- Blood Diseases and Resources Research 93.
846 -- Arthritis, Musculoskeletal and Skin Diseases Research 93. 847 -- Diabetes, Digestive, and Kidney Diseases Extramural Research 93. 853 -- Extramural Research Programs in the Neurosciences and Neurological Disorders 93.
855 -- Allergy, Immunology and Transplantation Research 93. 856 -- Microbiology and Infectious Diseases Research 93. 859 -- Biomedical Research and Research Training 93.
865 -- Child Health and Human Development Extramural Research 93.
867 -- Vision Research Cost Sharing or Matching Requirement:No Last Updated Date:Dec 19, 2013 Original Closing Date for Applications:Sep 07, 2014 Current Closing Date for Applications:Jan 07, 2014 Archive Date:Feb 07, 2014 Estimated Total Program Funding: Eligible Applicants:Native American tribal organizations (other than Federally recognized tribal governments) Native American tribal governments (Federally recognized) Special district governments Nonprofits having a 501(c)(3) status with the IRS, other than institutions of higher education Others (see text field entitled "Additional Information on Eligibility" for clarification) For profit organizations other than small businesses Private institutions of higher education City or township governments Nonprofits that do not have a 501(c)(3) status with the IRS, other than institutions of higher education Public and State controlled institutions of higher education Additional Information on Eligibility:Other Eligible Applicants include the following: Alaska Native and Native Hawaiian Serving Institutions; Faith-based or Community-based Organizations; Hispanic-serving Institutions; Historically Black Colleges and Universities (HBCUs); Indian/Native American Tribal Governments (Other than Federally Recognized); Tribally Controlled Colleges and Universities (TCCUs) ; U.S. Territory or Possession; Non-domestic (non-U.S.) Entities (Foreign Organizations) are not eligible to apply.
Foreign (non-U.S.) components of U.S. Organizations are not allowed. ## Additional Information Agency Name:National Institutes of Health Description:The primary purpose of the NIH Mentored Clinical Scientist Research Career Development Awards (K08) program is to prepare qualified individuals for careers that have a significant impact on the health-related research needs of the Nation.
This program represents the continuation of a long-standing NIH program that provides support and protected time to individuals with a clinical doctoral degree for an intensive, supervised research career development experience in the fields of biomedical and behavioral research, including translational research.
Individuals with a clinical doctoral degree interested in pursuing a career in patient-oriented research should refer to the NIH Mentored Patient-Oriented Research Career Development Award (Parent K23). Prospective candidates are encouraged to contact the relevant NIH staff for IC-specific programmatic and budgetary information: Table of IC-Specific Information, Requirements and Staff Contacts..
Link to Additional Information:http://grants. nih. gov/grants/guide/pa-files/PA-11-193.
html Grantor Contact Information:If you have difficulty accessing the full announcement electronically, please contact: If you have any problems linking to this funding announcement, please contact the NIH OER Webmaster #### Health & Human Services * Frequently Asked Questions ## Your session will expire in 3 minutes. To continue working, click on the "OK" button below. This is being done to protect your privacy.
Unsaved changes will be lost.
According to the current listing, eligibility includes: Applicants proposing human subject research on long-term complications of Type 1 Diabetes (diabetic eye, kidney, and cardiovascular disease). Confirm the full requirements in the official notice before applying.
Applications for FY27 Training Awards are due July 2, 2026. Build your timeline backwards from this date to cover registrations, approvals, and final submission checks.
FY27 Training Awards is funded by Breakthrough T1D (formerly JDRF). Verify program details on the funder's official page before applying.
Start from the official opportunity page linked in this listing — it carries the sponsor's submission instructions.
Past winners and funding trends for this program
S. 3971 reauthorized SBIR/STTR through 2031 after the longest lapse in the program's history. Buried inside are a new $30M Strategic Breakthrough Award, per-company proposal caps arriving in FY2027, eight-watchlist foreign-risk screening, and bigger TABA budgets. Here is what each change means for who wins and who gets squeezed out.
Read articleNSF restarted its SBIR/STTR programs on May 31, 2026 after a multi-month hiatus, with a $250 million FY26 allocation, a Project Pitch portal reopen on June 2, and a first full-proposal deadline of July 27, 2026. The big structural changes: a new Strategic Breakthrough tier that extends invited Phase II companies up to $30 million, and a $40 million pilot for next-generation scientific instrumentation. Phase I tops out at $305K, Phase II at $1.25M, with November 4 and March 4, 2027 windows behind the July 27 first deadline. For deep-tech startups that watched the NIH SBIR omnibus go dark and DARPA pull back on conventional Phase II slots, this is the most consequential reopening of the year — and the Strategic Breakthrough tier is the first time NSF has competed directly with venture capital at growth-stage check sizes.
Read articleOn May 31, NSF announced the restart of its SBIR and STTR programs with a \$250 million FY26 allocation, a Project Pitch portal reopening June 2, a first full-proposal deadline of July 27, 2026, and additional windows on November 4 and March 4, 2027. Phase I tops out at \$305K, Phase II at \$1.25M, and a new Strategic Breakthrough lane extends invited Phase II companies up to \$30M. A separate \$40M instrumentation pilot (NSF 26-511) funds next-generation scientific tools. Here is what changed from prior cycles, who the program actually fits, and how to position a Project Pitch for the July deadline.
Read article